{"id":"18f-fluoroestradiol-fes","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL4594261","moleculeType":"Small molecule","molecularWeight":"289.38"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"FES binds to estrogen receptors on tumor cells, allowing for visualization of estrogen receptor-positive tumors in the body. This can aid in diagnosis and treatment planning for patients with breast cancer and other estrogen receptor-positive cancers.","oneSentence":"FES is a radiolabeled estrogen receptor ligand used for imaging estrogen receptor-positive tumors.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:56:17.517Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Imaging of estrogen receptor-positive tumors"}]},"trialDetails":[],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"[18F]fluoroestradiol (FES)","genericName":"[18F]fluoroestradiol (FES)","companyName":"Asan Medical Center","companyId":"asan-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"FES is a radiolabeled estrogen receptor ligand used for imaging estrogen receptor-positive tumors. Used for Imaging of estrogen receptor-positive tumors.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":false,"score":2}}